GlassScriptPhysician profile
Edgar E Domenech Fagundo
NPI 1386717247
$1,906.87
in general payments reported to CMS, 2019-2025
12 companies · $615 in 2025
The $615 reported for 2025 was more than what 79% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $107 · 2021: $198 · 2022: $428 · 2023: $204 · 2024: $156 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $475.90 | 2019-2022 | |
| Medtronic, INC. | $448.31 | 2019-2025 | Propel, Signia, Endurant Iis |
| Boston Scientific Corporation | $316.21 | 2021-2025 | Watchman Flx, Emblem Mri S-Icd, Farapulse |
| E.R. Squibb & Sons, L.L.C. | $169.70 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $123.90 | 2022 | |
| Dexcom, INC. | $113.54 | 2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $68.01 | 2024 | Floseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.67 | 2020-2022 | |
| Becton, Dickinson and Company | $55.78 | 2024-2025 | Bardport M.R.I. |
| Johnson and Johnson International | $37.30 | 2023 | Harmonic |
| Pbg Puerto Rico LLC | $22.57 | 2022 | |
| Olympus Latin America, INC. | $14.98 | 2023 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Domenech Fagundo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.